Inhibrx Inc. (INBX) Social Stream



Inhibrx Inc. (INBX): $14.60

0.72 (+5.19%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add INBX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#80 of 334

in industry

INHIBRX INC (INBX) Price Targets From Analysts

Use the tables below to see what analysts covering INHIBRX INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-01 3 $55 $50 $52.666 $36.3 45.09%
2022-05-09 4 $55 $40 $49.5 $36.3 36.36%
2022-05-16 4 $53 $40 $47 $36.3 29.48%
2022-08-10 3 $50 $40 $43.75 $36.3 20.52%
2022-10-04 3 $56 $40 $45.25 $36.3 24.66%
2022-11-07 4 $60 $40 $48.2 $36.3 32.78%
2023-03-06 4 $60 $40 $47.8 $36.3 31.68%
2023-03-07 4 $60 $40 $48 $36.3 32.23%
2023-05-08 3 $60 $45 $53.333 $36.3 46.92%
2023-08-16 4 $60 $35 $48.75 $36.3 34.3%
2023-08-23 3 $55 $27 $42.333 $36.3 16.62%
2023-11-10 4 $55 $27 $39.25 $36.3 8.13%

The Trend in the Analyst Price Target


INBX's average price target has moved down $13.42 over the prior 21 months.

INBX reports an average of 122.37% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-06 4 60 40 47.800 23.69 101.77%
2023-05-08 4 60 45 53.333 26.45 101.64%
2023-05-10 4 60 35 48.750 25.86 88.52%
2023-08-23 4 55 27 42.333 19.44 117.76%
2023-08-23 3 60 27 46.750 19.44 140.48%

INBX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 23 months, INBX's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • INBX has a greater number of analysts covering the stock than 238.7% of all US stocks.
  • INHIBRX INC's average analyst price target is greater than 1869.44% of stocks in the small market cap category.
  • INBX has a lower variance in analysts' estimates than -439.67% of Pharmaceutical Products stocks.
  • INHIBRX INC's upside potential (average analyst target price relative to current price) is greater than 593.42% of Pharmaceutical Products stocks.

Stocks similar to INHIBRX INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HUMA, TSHA, and OPT.

Is INBX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!